Is DRIO or GDRX more undervalued in 2026?

CirclFi compares DarioHealth Corp. (DRIO) and GoodRx Holdings, Inc. (GDRX) using 13 institutional-grade valuation models. DRIO has a Quality of Company score of 6.3/10 while GDRX scores 7.7/10.

Which is a better buy — DRIO or GDRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do DRIO and GDRX valuations compare?

DRIO at $7.52 and GDRX at $2.97 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

DRIO vs GDRX Valuation Comparison 2026 — Intrinsic Value Analysis

DRIO

Health Information Services

DarioHealth Corp.

Quality

6.3

out of 10

Value Trap

LOW

Price

$7.52

Last close

Models

10/13

Active

GDRX

Health Information Services

GoodRx Holdings, Inc.

Quality

7.7

out of 10

Value Trap

LOW

Price

$2.97

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	DRIO Fair Value	DRIO Upside	GDRX Fair Value	GDRX Upside
Bayesian DCF	Intrinsic	$1.29	-82.8%	$9.08	+205.8%
Earnings Power Value	Intrinsic	$3.96	-45.7%	$1.54	-48.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for DRIO vs GDRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DRIO vs GDRX — Which Stock Is More Undervalued?

GDRX scores higher with a 7.7/10 quality rating vs DRIO's 6.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing DarioHealth Corp. (DRIO) and GoodRx Holdings, Inc. (GDRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DRIO currently trades at $7.52 with a QOC of 6.3/10, while GDRX trades at $2.97 with a QOC of 7.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).